Literature DB >> 30312851

Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties.

John W Hickey1, Ariel Y Isser2, Fernando P Vicente3, Samuel B Warner4, Hai-Quan Mao5, Jonathan P Schneck6.   

Abstract

Magnetic particles can enrich desired cell populations to aid in understanding cell-type functions and mechanisms, diagnosis, and therapy. As cells are heterogeneous in ligand type, location, expression, and density, careful consideration of magnetic particle design for positive isolation is necessary. Antigen-specific immune cells have low frequencies, which has made studying, identifying, and utilizing these cells for therapy a challenge. Here we demonstrate the importance of magnetic particle design based on the biology of T cells. We create magnetic particles which recognize rare antigen-specific T cells and quantitatively investigate important particle properties including size, concentration, ligand density, and ligand choice in enriching these rare cells. We observe competing optima among particle parameters, with 300 nm particles functionalized with a high density of antigen-specific ligand achieving the highest enrichment and recovery of target cells. In enriching and then activating an endogenous response, 300 nm aAPCs generate nearly 65% antigen-specific T cells with at least 450-fold expansion from endogenous precursors and a 5-fold increase in numbers of antigen-specific cells after only seven days. This systematic study of particle properties in magnetic enrichment provides a case study for the engineering design principles of particles for the isolation of rare cells through biological ligands.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Artificial antigen-presenting cells; Immunotherapy; Magnetic enrichment; Nanoparticles; Size; T cells

Mesh:

Substances:

Year:  2018        PMID: 30312851      PMCID: PMC6284398          DOI: 10.1016/j.biomaterials.2018.09.029

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  39 in total

1.  Magnetic cell separation: characterization of magnetophoretic mobility.

Authors:  Kara E McCloskey; Jeffrey J Chalmers; Maciej Zborowski
Journal:  Anal Chem       Date:  2003-12-15       Impact factor: 6.986

2.  Soluble MHC-peptide complexes induce rapid death of CD8+ CTL.

Authors:  Marek Cebecauer; Philippe Guillaume; Pavel Hozák; Silke Mark; Helen Everett; Pascal Schneider; Immanuel F Luescher
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

3.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.

Authors:  B Devika Chithrani; Arezou A Ghazani; Warren C W Chan
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

4.  Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.

Authors:  Karlo Perica; Joan Glick Bieler; Christian Schütz; Juan Carlos Varela; Jacqueline Douglass; Andrew Skora; Yen Ling Chiu; Mathias Oelke; Kenneth Kinzler; Shibin Zhou; Bert Vogelstein; Jonathan P Schneck
Journal:  ACS Nano       Date:  2015-07-14       Impact factor: 15.881

Review 5.  The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude.

Authors:  Marc K Jenkins; James J Moon
Journal:  J Immunol       Date:  2012-05-01       Impact factor: 5.422

6.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.

Authors:  Carolina Berger; Michael C Jensen; Peter M Lansdorp; Mike Gough; Carole Elliott; Stanley R Riddell
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

7.  T cell activation is determined by the number of presented antigens.

Authors:  Janosch Deeg; Markus Axmann; Jovana Matic; Anastasia Liapis; David Depoil; Jehan Afrose; Silvia Curado; Michael L Dustin; Joachim P Spatz
Journal:  Nano Lett       Date:  2013-10-17       Impact factor: 11.189

Review 8.  Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells.

Authors:  Evan W Newell; Mark M Davis
Journal:  Nat Biotechnol       Date:  2014-01-19       Impact factor: 54.908

9.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Authors:  Jorge R Almeida; David A Price; Laura Papagno; Zaïna Aït Arkoub; Delphine Sauce; Ethan Bornstein; Tedi E Asher; Assia Samri; Aurélie Schnuriger; Ioannis Theodorou; Dominique Costagliola; Christine Rouzioux; Henri Agut; Anne-Geneviève Marcelin; Daniel Douek; Brigitte Autran; Victor Appay
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

10.  Full control of ligand positioning reveals spatial thresholds for T cell receptor triggering.

Authors:  Haogang Cai; James Muller; David Depoil; Viveka Mayya; Michael P Sheetz; Michael L Dustin; Shalom J Wind
Journal:  Nat Nanotechnol       Date:  2018-04-30       Impact factor: 39.213

View more
  10 in total

1.  Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles.

Authors:  John W Hickey; Jonathan P Schneck
Journal:  J Vis Exp       Date:  2018-11-17       Impact factor: 1.355

Review 2.  Applications of molecular engineering in T-cell-based immunotherapies.

Authors:  David A McBride; Matthew D Kerr; Shinya L Wai; Nisarg J Shah
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-04-10

Review 3.  Nanoparticles for generating antigen-specific T cells for immunotherapy.

Authors:  Savannah E Est-Witte; Natalie K Livingston; Mary O Omotoso; Jordan J Green; Jonathan P Schneck
Journal:  Semin Immunol       Date:  2021-12-23       Impact factor: 11.130

4.  Synthetic Antigen-Presenting Cells for Adoptive T Cell Therapy.

Authors:  Shreyas N Dahotre; Anna M Romanov; Fang-Yi Su; Gabriel A Kwong
Journal:  Adv Ther (Weinh)       Date:  2021-03-18

5.  Engineering an Artificial T-Cell Stimulating Matrix for Immunotherapy.

Authors:  John W Hickey; Yi Dong; Jae Wook Chung; Sebastian F Salathe; Hawley C Pruitt; Xiaowei Li; Calvin Chang; Andrew K Fraser; Catherine A Bessell; Andrew J Ewald; Sharon Gerecht; Hai-Quan Mao; Jonathan P Schneck
Journal:  Adv Mater       Date:  2019-04-10       Impact factor: 30.849

Review 6.  Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.

Authors:  Ariel Isser; Natalie K Livingston; Jonathan P Schneck
Journal:  Biomaterials       Date:  2020-12-05       Impact factor: 15.304

7.  Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cells.

Authors:  John W Hickey; Ariel Isser; Sebastian F Salathe; Kayla M Gee; Meng-Hsuan Hsiao; Wasamah Shaikh; Nkechi C Uzoukwu; Joan Glick Bieler; Hai-Quan Mao; Jonathan P Schneck
Journal:  Nano Lett       Date:  2020-06-28       Impact factor: 12.262

8.  Dendritic cell-mimicking scaffolds for ex vivo T cell expansion.

Authors:  Hye Sung Kim; Tzu-Chieh Ho; Moshe J Willner; Michael W Becker; Hae-Won Kim; Kam W Leong
Journal:  Bioact Mater       Date:  2022-09-11

9.  Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy.

Authors:  Ariel Isser; Aliyah B Silver; Hawley C Pruitt; Michal Mass; Emma H Elias; Gohta Aihara; Si-Sim Kang; Niklas Bachmann; Ying-Yu Chen; Elissa K Leonard; Joan G Bieler; Worarat Chaisawangwong; Joseph Choy; Sydney R Shannon; Sharon Gerecht; Jeffrey S Weber; Jamie B Spangler; Jonathan P Schneck
Journal:  Nat Commun       Date:  2022-10-14       Impact factor: 17.694

Review 10.  Improving cancer immunotherapy through nanotechnology.

Authors:  Michael S Goldberg
Journal:  Nat Rev Cancer       Date:  2019-09-06       Impact factor: 60.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.